PTK2 and cancer: We hypothesized that FAK inhibitors decrease pro-survival function of FAK and make cancer cells more vulnerable to additional stress, but this discrepancy in data suggests that inhibition of kinase function of FAK with kinase inhibitor affects different mechanisms/pathways in cancer cell than PPI inhibitor.